Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Uhl

Showing results (361-370 of 526) with videos related to

Pageof 53
Sort By:
Neuropsychopharmacology Reports|February 6, 2019
Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout miceYoshiyuki Kasahara, Yasufumi Sakakibara, Takashi Hiratsuka, et al.
Biological Psychiatry|March 6, 2007
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasisMartin O Job, Amanda Tang, F Scott Hall, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|May 29, 2004
Regulation of dopamine and MPP+ transport by catecholamine transportersToshihiro Dohi, Shigeo Kitayama, Norimitsu Morioka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2006
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout miceMotoyasu Yamashita, Setsu Fukushima, Hao-wei Shen, et al.
Synapse (New York, N.Y.)|June 21, 2008
Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawalNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effectsGeorge R Uhl, Tomas Drgon, Catherine Johnson, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazidVanja M Bulatovic, Nancy L Wengenack, James R Uhl, et al.
The Biochemical Journal|September 17, 2003
GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKAQing-Rong Liu, Ping-Wu Zhang, Zhicheng Lin, et al.
The International Journal of Neuroscience|March 2, 2012
Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouseEpolia Ramadan, Lisa Chang, Mei Chen, et al.
Synapse (New York, N.Y.)|September 1, 1995
Ligand selectivity of cloned human and rat opioid mu receptorsR B Rothman, H Xu, J B Wang, et al.
Pageof 53

Showing results (361-370 of 526) with videos related to

Sort By:
Pageof 53
Neuropsychopharmacology Reports|February 6, 2019
Repeated methamphetamine treatment increases spine density in the nucleus accumbens of serotonin transporter knockout miceYoshiyuki Kasahara, Yasufumi Sakakibara, Takashi Hiratsuka, et al.
Biological Psychiatry|March 6, 2007
Mu (mu) opioid receptor regulation of ethanol-induced dopamine response in the ventral striatum: evidence of genotype specific sexual dimorphic epistasisMartin O Job, Amanda Tang, F Scott Hall, et al.
Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology|May 29, 2004
Regulation of dopamine and MPP+ transport by catecholamine transportersToshihiro Dohi, Shigeo Kitayama, Norimitsu Morioka, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 13, 2006
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout miceMotoyasu Yamashita, Setsu Fukushima, Hao-wei Shen, et al.
Synapse (New York, N.Y.)|June 21, 2008
Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawalNobue Kitanaka, Junichi Kitanaka, F Scott Hall, et al.
Annals of the New York Academy of Sciences|November 11, 2008
Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effectsGeorge R Uhl, Tomas Drgon, Catherine Johnson, et al.
Antimicrobial Agents and Chemotherapy|August 17, 2002
Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazidVanja M Bulatovic, Nancy L Wengenack, James R Uhl, et al.
The Biochemical Journal|September 17, 2003
GBPI, a novel gastrointestinal- and brain-specific PP1-inhibitory protein, is activated by PKC and inactivated by PKAQing-Rong Liu, Ping-Wu Zhang, Zhicheng Lin, et al.
The International Journal of Neuroscience|March 2, 2012
Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouseEpolia Ramadan, Lisa Chang, Mei Chen, et al.
Synapse (New York, N.Y.)|September 1, 1995
Ligand selectivity of cloned human and rat opioid mu receptorsR B Rothman, H Xu, J B Wang, et al.
Pageof 53